Pua, Abdulhakim G.
HRN: 21-64-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
CEFTAZIDIME 1GM (VIAL)
07/25/2022
07/31/2022
IV
2g
Q8h
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes